Brumm Joshua T Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
19
Insider Sells Sum
$24.24M

Insider Activity of Brumm Joshua T

According to the SEC Form 4 filings, Brumm Joshua T, being in a position of

  1. Chief Executive Officer at Crescent Biopharma, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 51752 shares for $920,842,
    over all time since 2026-06-22, has bought 0 shares, and sold 51752 shares for $920,842.

Biography of Brumm Joshua T

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $920,8423100

Comparison of Insiders on Amount of Buys and Sells

2026-09-18SaleCrescent Biopharma, Inc.
CBIO
Chief Executive Officer
7,837
0.0209%
$16.71$130,956-19.86%
2026-09-16SaleCrescent Biopharma, Inc.
CBIO
Chief Executive Officer
1,610
0.0045%
$17.90$28,819-19.94%
2026-06-22SaleCrescent Biopharma, Inc.
CBIO
Chief Executive Officer
42,305
0.1571%
$17.99$761,067-6.49%
2024-03-11SaleDyne Therapeutics, Inc.
DYN
CEO & President
66,387
0.0547%
$25.67$1.7M+15.11%
2024-03-08SaleDyne Therapeutics, Inc.
DYN
CEO & President
363,343
0.3025%
$25.93$9.42M+17.01%
2024-03-07SaleDyne Therapeutics, Inc.
DYN
CEO & President
9,086
0.0075%
$25.85$234,873+11.23%
2024-03-01SaleDyne Therapeutics, Inc.
DYN
CEO & President
94,480
0.0881%
$29.04$2.74M+1.06%
2024-02-29SaleDyne Therapeutics, Inc.
DYN
CEO & President
5,520
0.0049%
$27.50$151,800+9.33%
2024-01-04SaleDyne Therapeutics, Inc.
DYN
CEO & President
218,536
0.1299%
$18.51$4.05M+51.52%
2024-01-03SaleDyne Therapeutics, Inc.
DYN
CEO & President
51,183
0.0317%
$19.28$986,957+98.78%
2023-12-11SaleDyne Therapeutics, Inc.
DYN
See Remarks
7,585
0.0026%
$10.72$81,311+169.36%
2023-09-18SaleDyne Therapeutics, Inc.
DYN
See Remarks
12,032
0.0036%
$9.41$113,221+159.9%
2023-09-12SaleDyne Therapeutics, Inc.
DYN
See Remarks
7,672
0.0026%
$10.41$79,866+156.31%
2023-06-12SaleDyne Therapeutics, Inc.
DYN
See Remarks
187,748
0.076%
$12.61$2.37M-4.87%
2023-06-09SaleDyne Therapeutics, Inc.
DYN
See Remarks
76,582
0.0328%
$13.34$1.02M-8.26%
2023-06-08SaleDyne Therapeutics, Inc.
DYN
See Remarks
61,000
0.0259%
$13.22$806,690-11.66%
2023-03-14SaleDyne Therapeutics, Inc.
DYN
See Remarks
7,318
0.0031%
$13.33$97,549-14.74%
2022-12-12SaleDyne Therapeutics, Inc.
DYN
See Remarks
3,322
0.0012%
$10.87$36,110-1.72%
2022-10-07SaleDyne Therapeutics, Inc.
DYN
See Remarks
14,200
0.0061%
$13.37$189,854-8.96%
2022-03-11SaleDyne Therapeutics, Inc.
DYN
See Remarks
3,384
0.0009%
$8.73$29,542+25.97%
Total: 22
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.